Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

Researchers have been searching for a diabetes cure or a long-term solution for managing type 1 diabetes for decades now. They not only have to find a way to restore insulin production but also need ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered ...

A patient with type 1 diabetes has begun producing his own insulin after receiving a transplant of pancreatic cells.

The procedure, carried out by researchers at Uppsala University in Sweden, allowed the patient to begin producing small amounts of his own insulin for the first time in years ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...